160 related articles for article (PubMed ID: 26171704)
1. Anemia in the Neonate: The Differential Diagnosis and Treatment.
Nassin ML; Lapping-Carr G; de Jong JL
Pediatr Ann; 2015 Jul; 44(7):e159-63. PubMed ID: 26171704
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skin.
Voit RA; Grace RF
Blood; 2020 Aug; 136(6):770. PubMed ID: 32761227
[No Abstract] [Full Text] [Related]
3. Hemolytic anemia associated with a novel heterozygote mutation 1183A in the PK-LR gene (PK- Jordan).
Karadsheh NS; Gelbart T; Naffa RG
Int J Lab Hematol; 2014 Aug; 36(4):e66-8. PubMed ID: 24330591
[No Abstract] [Full Text] [Related]
4. A previously unknown mutation in the pyruvate kinase gene (PKLR) identified from a neonate with severe jaundice.
Yaish HM; Nussenzveig RH; Agarwal AM; Siddiqui AH; Christensen RD
Neonatology; 2014; 106(2):140-2. PubMed ID: 24969675
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency.
Dulmovits BM; Wild KT; Flibotte J; Lambert MP; Kwiatkowski J; Thom CS
Neonatology; 2023; 120(5):661-665. PubMed ID: 37473739
[TBL] [Abstract][Full Text] [Related]
6. Management of pyruvate kinase deficiency in children and adults.
Grace RF; Barcellini W
Blood; 2020 Sep; 136(11):1241-1249. PubMed ID: 32702739
[TBL] [Abstract][Full Text] [Related]
7. A novel PKLR gene mutation identified using advanced molecular techniques.
He Y; Luo J; Lei Y; Jia S; Liao N
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29349879
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase deficiency mimicking congenital dyserythropoietic anemia type I.
Yozgat AK; Erdem AY; Kaçar D; Özbek NY; Yaralı N
Turk J Pediatr; 2022; 64(5):951-955. PubMed ID: 36305449
[TBL] [Abstract][Full Text] [Related]
9. Novel PLKR mutations in four families with pyruvate kinase deficiency.
Qin L; Nie Y; Chen L; Zhang D; Lin Y; Ru K
Int J Lab Hematol; 2020 Apr; 42(2):e84-e87. PubMed ID: 31747117
[No Abstract] [Full Text] [Related]
10. A Case With Pyruvate Kinase Deficiency Remarkably Sensitive to Heat.
Aksu T; Yarali N; Fermo E; Marcello A; Hacisalihoğlu Ş; Bianchi P; Özbek NY
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e458-e460. PubMed ID: 29309376
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate kinase deficiency and severe congenital hemolytic anemia in a double heterozygous patient with paternal transmission of an early germ-line de novo mutation.
Mañú-Pereira Mdel M; Gonzalez-Roca E; van Solinge WW; Llaudet-Planas E; Sevilla J; Montllor L; Mensa-Vilaro A; Ploos van Amstel HK; van Wijk R; Vives-Corrons J
Am J Hematol; 2015 Dec; 90(12):E217-9. PubMed ID: 26315463
[No Abstract] [Full Text] [Related]
12. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India.
Warang P; Kedar P; Ghosh K; Colah R
Blood Cells Mol Dis; 2013 Oct; 51(3):133-7. PubMed ID: 23770304
[TBL] [Abstract][Full Text] [Related]
13. Red cell pyruvate kinase deficiency in Spain: A study of 15 cases.
Montllor L; Mañú-Pereira MD; Llaudet-Planas E; Gómez Ramírez P; Sevilla Navarro J; Vives-Corrons JL
Med Clin (Barc); 2017 Jan; 148(1):23-27. PubMed ID: 27871768
[TBL] [Abstract][Full Text] [Related]
14. Co-inheritance of G6PD and PK deficiencies in a neonate carrying a Novel UGT1A1 genotype associated to Crigler-Najjar type II syndrome.
Minucci A; Ruggiero A; Canu G; Maurizi P; De Bonis M; Concolino P; De Luca D; Capoluongo E
Pediatr Blood Cancer; 2015 Sep; 62(9):1680-1. PubMed ID: 25822733
[No Abstract] [Full Text] [Related]
15. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
Grace RF; Bianchi P; van Beers EJ; Eber SW; Glader B; Yaish HM; Despotovic JM; Rothman JA; Sharma M; McNaull MM; Fermo E; Lezon-Geyda K; Morton DH; Neufeld EJ; Chonat S; Kollmar N; Knoll CM; Kuo K; Kwiatkowski JL; Pospíšilová D; Pastore YD; Thompson AA; Newburger PE; Ravindranath Y; Wang WC; Wlodarski MW; Wang H; Holzhauer S; Breakey VR; Kunz J; Sheth S; Rose MJ; Bradeen HA; Neu N; Guo D; Al-Sayegh H; London WB; Gallagher PG; Zanella A; Barcellini W
Blood; 2018 May; 131(20):2183-2192. PubMed ID: 29549173
[TBL] [Abstract][Full Text] [Related]
16. Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood. 1962;19(3):267-295.
Blood; 2016 May; 127(21):2505. PubMed ID: 27231390
[No Abstract] [Full Text] [Related]
17. Compound heterozygosity in
Bagla S; Bhambhani K; Gadgeel M; Buck S; Jin JP; Ravindranath Y
Haematologica; 2019 Sep; 104(9):e428-e431. PubMed ID: 30948487
[No Abstract] [Full Text] [Related]
18. Molecular genetic testing enabled the diagnosis of otherwise undiagnosable cases of pyruvate kinase deficiency.
Chueh HW; Kim N
Pediatr Hematol Oncol; 2022 Mar; 39(2):166-173. PubMed ID: 34281465
[TBL] [Abstract][Full Text] [Related]
19. Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
Schwartz JD; Barcellini W; Grace RF; Bianchi P; Zanella A; López Lorenzo JL; Sevilla J; Shah AJ; Glader B; Nicoletti E; Navarro Ordoñez S; Segovia JC
Am J Hematol; 2022 Mar; 97(3):E120-E125. PubMed ID: 34989415
[No Abstract] [Full Text] [Related]
20. Consensus document for the diagnosis and treatment of pyruvate kinase deficiency.
Morado M; Villegas AM; de la Iglesia S; Martínez-Nieto J; Del Orbe Barreto R; Beneitez D; Salido E;
Med Clin (Barc); 2021 Sep; 157(5):253.e1-253.e8. PubMed ID: 33431182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
